Biontech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/16/24 EDT
86.40UNCH (UNCH)
Volume
1,216,495
52 week range
85.21 - 129.10
Loading...
  • Open86.63
  • Day High86.88
  • Day Low85.40
  • Prev Close86.40
  • 52 Week High129.10
  • 52 Week High Date04/17/23
  • 52 Week Low85.21
  • 52 Week Low Date03/20/24

Key Stats

  • Market Cap20.54B
  • Shares Out237.73M
  • 10 Day Average Volume0.56M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change-18.14

KEY STATS

  • Open86.63
  • Day High86.88
  • Day Low85.40
  • Prev Close86.40
  • 52 Week High129.10
  • 52 Week High Date04/17/23
  • 52 Week Low85.21
  • 52 Week Low Date03/20/24
  • Market Cap20.54B
  • Shares Out237.73M
  • 10 Day Average Volume0.56M
  • Dividend-
  • Dividend Yield-
  • Beta0.25
  • YTD % Change-18.14

RATIOS/PROFITABILITY

  • EPS (TTM)39.99
  • P/E (TTM)2.16
  • Fwd P/E (NTM)-89.31
  • EBITDA (TTM)1.121B
  • ROE (TTM)4.62%
  • Revenue (TTM)4.055B
  • Gross Margin (TTM)84.29%
  • Net Margin (TTM)24.36%
  • Debt To Equity (MRQ)1.08%

EVENTS

  • Earnings Date05/06/2024
  • Ex Div Date06/02/2022
  • Div Amount2.1322
  • Split Date-
  • Split Factor-

Latest On Biontech SE

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific...
Ugur Sahin M.D.
Chief Executive Officer, Member of the Management Board
Sierk Poetting Ph.D.
Chief Operating Officer, Member of the Management Board
Jens Holstein
Chief Financial Officer
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
118.29UNCHUNCH
GMAB
Genmab A/S
28.53UNCHUNCH
INCY
Incyte Corp
52.72UNCHUNCH
CRL
Charles River Laboratories International Inc
230.09UNCHUNCH
ALNY
Alnylam Pharmaceuticals Inc
145.32UNCHUNCH